Login to Your Account

FDA Plan Could Lead To Faster Review Times For Biologics

By Kim Coghill

Monday, September 9, 2002
The FDA intends to speed the review time of biologics by transferring the application process from the biologics center to the drug center.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription